It is an amantadine derivative with low to moderate-affinity for NMDA receptors. Holding a highly reputed and trusted market standing, we are engaged in offering Oseltamivir Phosphate. It is indicated for the treatment of moderate to severe dementia of the alzheimer's type. This drug exerts its action through uncompetitive NMDA receptor antagonism, binding preferentially to the NMDA receptor-operated cation channels. Oseltamivir Phosphate is associated with a minimal rate of serum enzyme elevations during therapy. We offer this drug to clients at pocket friendly prices.